Correlation Between MiMedx and United States

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MiMedx and United States at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MiMedx and United States into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MiMedx Group and United States 12, you can compare the effects of market volatilities on MiMedx and United States and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MiMedx with a short position of United States. Check out your portfolio center. Please also check ongoing floating volatility patterns of MiMedx and United States.

Diversification Opportunities for MiMedx and United States

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between MiMedx and United is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding MiMedx Group and United States 12 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United States 12 and MiMedx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MiMedx Group are associated (or correlated) with United States. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United States 12 has no effect on the direction of MiMedx i.e., MiMedx and United States go up and down completely randomly.

Pair Corralation between MiMedx and United States

Given the investment horizon of 90 days MiMedx Group is expected to under-perform the United States. In addition to that, MiMedx is 3.22 times more volatile than United States 12. It trades about -0.3 of its total potential returns per unit of risk. United States 12 is currently generating about 0.13 per unit of volatility. If you would invest  3,958  in United States 12 on January 25, 2024 and sell it today you would earn a total of  92.00  from holding United States 12 or generate 2.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

MiMedx Group  vs.  United States 12

 Performance 
       Timeline  
MiMedx Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MiMedx Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
United States 12 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in United States 12 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, United States may actually be approaching a critical reversion point that can send shares even higher in May 2024.

MiMedx and United States Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MiMedx and United States

The main advantage of trading using opposite MiMedx and United States positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MiMedx position performs unexpectedly, United States can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United States will offset losses from the drop in United States' long position.
The idea behind MiMedx Group and United States 12 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets